by Vandana Singh | Jul 22, 2026 | General
On Wednesday, the U.S. Food and Drug Administration (FDA) granted early approval to GSK plc’s (NYSE:GSK) targeted lung cancer medication, Jideytro (zidesamtinib). The regulatory green light authorizes the therapy for adult patients facing locally advanced or...
by Kaustubh Bagalkote | Jul 22, 2026 | General
Red Cat Holdings Inc. (NASDAQ:RCAT) stock gapped lower at Wednesday’s market open after the company disclosed the termination of its chief revenue officer and a related legal dispute. The broader market was mixed, with the Nasdaq rising 0.03% and the S&P 500...
by Evette Mitkov | Jul 22, 2026 | General
ServiceNow Inc (NYSE:NOW) shares are declining Wednesday after a report detailing OpenAI’s push deeper into enterprise software rattled investor confidence in legacy workflow automation platforms, with an earnings report due after the close adding another layer of...
by Lekha Gupta | Jul 22, 2026 | General
CrowdStrike Holdings Inc. (NASDAQ:CRWD) and Cerebras Systems Inc. (NASDAQ:CBRS) announced a strategic partnership Wednesday to strengthen artificial intelligence-powered cybersecurity. Under the agreement, CrowdStrike will use Cerebras’ AI inference technology to...
by Vandana Singh | Jul 22, 2026 | General
The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s (NYSE:JNJ) OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform. The marketing...
Recent Comments